P T. 2015 Feb;40(2):106-22.
P & T : a peer-reviewed journal for formulary management
Kunj Gohil
PMID: 25673958 PMCID: PMC4315110
Blinatumomab (Blincyto) for acute lymphoblastic leukemia; human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) for extended protection against cervical cancer; and hydrocodone bitartrate extended release (Hysingla ER) for 24-hour management of severe pain.